Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 42 | 2025 | 805 | 6.910 |
Why?
|
Genome-Wide Association Study | 62 | 2025 | 327 | 6.720 |
Why?
|
Alzheimer Disease | 23 | 2025 | 561 | 5.530 |
Why?
|
Polymorphism, Single Nucleotide | 48 | 2025 | 457 | 4.290 |
Why?
|
Cognitive Dysfunction | 11 | 2025 | 276 | 4.030 |
Why?
|
Genetic Predisposition to Disease | 41 | 2025 | 679 | 4.020 |
Why?
|
Transcriptome | 13 | 2021 | 337 | 3.910 |
Why?
|
Longitudinal Studies | 35 | 2025 | 1239 | 3.450 |
Why?
|
Genetic Variation | 23 | 2025 | 368 | 3.210 |
Why?
|
Neuropsychological Tests | 10 | 2025 | 353 | 3.100 |
Why?
|
Male | 128 | 2025 | 27987 | 2.400 |
Why?
|
Cognition | 10 | 2025 | 466 | 2.350 |
Why?
|
Female | 130 | 2025 | 31257 | 2.270 |
Why?
|
Aged | 82 | 2025 | 13599 | 2.230 |
Why?
|
Middle Aged | 95 | 2025 | 16552 | 2.220 |
Why?
|
Humans | 183 | 2025 | 60164 | 2.040 |
Why?
|
Electrocardiography | 13 | 2023 | 529 | 2.030 |
Why?
|
Aging | 12 | 2023 | 731 | 1.880 |
Why?
|
Gene Regulatory Networks | 9 | 2020 | 142 | 1.790 |
Why?
|
Biomarkers | 20 | 2025 | 1215 | 1.750 |
Why?
|
Heart Failure | 9 | 2025 | 869 | 1.720 |
Why?
|
DNA Methylation | 9 | 2023 | 276 | 1.700 |
Why?
|
Genetic Loci | 16 | 2020 | 104 | 1.670 |
Why?
|
Quantitative Trait Loci | 16 | 2024 | 71 | 1.670 |
Why?
|
Genomics | 10 | 2024 | 317 | 1.660 |
Why?
|
Coronary Artery Disease | 5 | 2023 | 275 | 1.620 |
Why?
|
Dementia | 4 | 2022 | 252 | 1.530 |
Why?
|
Aged, 80 and over | 28 | 2025 | 5202 | 1.400 |
Why?
|
Cardiovascular Diseases | 12 | 2023 | 832 | 1.400 |
Why?
|
Heart Atria | 5 | 2023 | 138 | 1.360 |
Why?
|
Myocardial Infarction | 5 | 2024 | 869 | 1.340 |
Why?
|
Exercise | 5 | 2024 | 919 | 1.340 |
Why?
|
Risk Factors | 36 | 2025 | 5091 | 1.340 |
Why?
|
Gene Expression Profiling | 16 | 2020 | 713 | 1.260 |
Why?
|
Heart Rate | 5 | 2025 | 308 | 1.250 |
Why?
|
Exome | 10 | 2024 | 74 | 1.250 |
Why?
|
Quantitative Trait, Heritable | 5 | 2023 | 27 | 1.230 |
Why?
|
tau Proteins | 3 | 2025 | 104 | 1.130 |
Why?
|
Genotype | 20 | 2025 | 643 | 1.120 |
Why?
|
Gene Expression | 9 | 2020 | 808 | 1.120 |
Why?
|
Whole Genome Sequencing | 6 | 2025 | 63 | 1.120 |
Why?
|
Cohort Studies | 26 | 2025 | 2481 | 1.110 |
Why?
|
Inflammation | 9 | 2024 | 1112 | 1.100 |
Why?
|
Genetic Association Studies | 7 | 2020 | 119 | 1.050 |
Why?
|
Echocardiography | 7 | 2023 | 460 | 1.030 |
Why?
|
Gene Expression Regulation | 11 | 2023 | 1543 | 1.010 |
Why?
|
Machine Learning | 4 | 2024 | 150 | 0.990 |
Why?
|
Blood Proteins | 3 | 2020 | 71 | 0.970 |
Why?
|
Polysomnography | 1 | 2025 | 54 | 0.950 |
Why?
|
Multifactorial Inheritance | 6 | 2025 | 22 | 0.940 |
Why?
|
Amyloid | 1 | 2025 | 63 | 0.930 |
Why?
|
Brain | 8 | 2025 | 1493 | 0.930 |
Why?
|
Phenotype | 17 | 2025 | 1158 | 0.930 |
Why?
|
Wearable Electronic Devices | 2 | 2024 | 65 | 0.930 |
Why?
|
Positron-Emission Tomography | 1 | 2025 | 174 | 0.900 |
Why?
|
Natural Language Processing | 1 | 2024 | 68 | 0.890 |
Why?
|
Outpatients | 1 | 2025 | 140 | 0.890 |
Why?
|
Computational Biology | 11 | 2024 | 337 | 0.880 |
Why?
|
Vascular Calcification | 1 | 2023 | 21 | 0.870 |
Why?
|
Heart | 4 | 2022 | 276 | 0.860 |
Why?
|
Proteomics | 3 | 2020 | 264 | 0.860 |
Why?
|
Metabolomics | 2 | 2021 | 53 | 0.850 |
Why?
|
MicroRNAs | 8 | 2024 | 620 | 0.850 |
Why?
|
Adult | 46 | 2025 | 15989 | 0.840 |
Why?
|
Sleep | 2 | 2025 | 223 | 0.820 |
Why?
|
Sequence Analysis, Protein | 6 | 2008 | 33 | 0.810 |
Why?
|
Prospective Studies | 16 | 2025 | 3132 | 0.780 |
Why?
|
Patient Compliance | 1 | 2024 | 373 | 0.780 |
Why?
|
Mass Screening | 2 | 2025 | 662 | 0.780 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2024 | 419 | 0.770 |
Why?
|
Metabolome | 1 | 2021 | 24 | 0.740 |
Why?
|
Cognition Disorders | 1 | 2022 | 219 | 0.730 |
Why?
|
Artificial Intelligence | 8 | 2023 | 173 | 0.720 |
Why?
|
Carrier Proteins | 4 | 2020 | 704 | 0.720 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2021 | 98 | 0.710 |
Why?
|
White Matter | 2 | 2023 | 114 | 0.710 |
Why?
|
LIM Domain Proteins | 1 | 2020 | 29 | 0.700 |
Why?
|
Proteome | 1 | 2021 | 142 | 0.690 |
Why?
|
Haplotypes | 8 | 2024 | 117 | 0.690 |
Why?
|
Cholesterol, LDL | 1 | 2020 | 105 | 0.690 |
Why?
|
Proteins | 10 | 2017 | 743 | 0.690 |
Why?
|
Homeodomain Proteins | 5 | 2020 | 257 | 0.680 |
Why?
|
Databases, Protein | 10 | 2017 | 47 | 0.680 |
Why?
|
Mobile Applications | 4 | 2024 | 130 | 0.670 |
Why?
|
Incidence | 12 | 2022 | 1267 | 0.660 |
Why?
|
Epigenesis, Genetic | 6 | 2023 | 354 | 0.660 |
Why?
|
Prefrontal Cortex | 1 | 2020 | 115 | 0.650 |
Why?
|
Muscle Proteins | 4 | 2020 | 110 | 0.610 |
Why?
|
Forecasting | 2 | 2019 | 221 | 0.610 |
Why?
|
Genome, Human | 5 | 2025 | 222 | 0.600 |
Why?
|
Heart Diseases | 3 | 2017 | 206 | 0.600 |
Why?
|
Microfilament Proteins | 3 | 2020 | 110 | 0.580 |
Why?
|
Alcoholism | 1 | 2020 | 308 | 0.550 |
Why?
|
Vaccines | 2 | 2008 | 97 | 0.550 |
Why?
|
Interleukin-6 | 4 | 2024 | 309 | 0.530 |
Why?
|
Models, Genetic | 5 | 2021 | 258 | 0.530 |
Why?
|
Gene Frequency | 8 | 2025 | 129 | 0.510 |
Why?
|
Risk Assessment | 9 | 2025 | 1937 | 0.510 |
Why?
|
Transcription Factors | 5 | 2020 | 1482 | 0.480 |
Why?
|
DNA | 2 | 2019 | 810 | 0.470 |
Why?
|
Receptors, Interleukin-6 | 2 | 2014 | 15 | 0.470 |
Why?
|
Long QT Syndrome | 3 | 2021 | 30 | 0.470 |
Why?
|
Algorithms | 12 | 2020 | 1006 | 0.460 |
Why?
|
Smartphone | 3 | 2024 | 64 | 0.460 |
Why?
|
Hypertension | 5 | 2021 | 603 | 0.430 |
Why?
|
Body Mass Index | 7 | 2024 | 893 | 0.430 |
Why?
|
Peptides | 5 | 2011 | 550 | 0.420 |
Why?
|
C-Reactive Protein | 5 | 2018 | 168 | 0.420 |
Why?
|
Follow-Up Studies | 6 | 2021 | 2363 | 0.420 |
Why?
|
Blood Pressure | 6 | 2023 | 522 | 0.420 |
Why?
|
Aorta | 2 | 2024 | 106 | 0.420 |
Why?
|
Computers, Handheld | 2 | 2025 | 37 | 0.410 |
Why?
|
Apolipoprotein E4 | 2 | 2025 | 35 | 0.410 |
Why?
|
Heart Conduction System | 3 | 2018 | 49 | 0.410 |
Why?
|
Massachusetts | 9 | 2024 | 2119 | 0.400 |
Why?
|
Precision Medicine | 2 | 2024 | 105 | 0.390 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2018 | 292 | 0.390 |
Why?
|
Models, Cardiovascular | 2 | 2022 | 77 | 0.380 |
Why?
|
Obesity | 6 | 2023 | 1191 | 0.350 |
Why?
|
Lipids | 2 | 2019 | 306 | 0.350 |
Why?
|
Arrhythmias, Cardiac | 2 | 2022 | 143 | 0.350 |
Why?
|
Mendelian Randomization Analysis | 5 | 2022 | 14 | 0.340 |
Why?
|
Chromosome Mapping | 4 | 2022 | 293 | 0.340 |
Why?
|
Proportional Hazards Models | 5 | 2024 | 679 | 0.340 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2008 | 132 | 0.340 |
Why?
|
Body Height | 2 | 2022 | 75 | 0.340 |
Why?
|
CpG Islands | 5 | 2023 | 213 | 0.330 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2022 | 33 | 0.330 |
Why?
|
Ventricular Function, Left | 3 | 2025 | 264 | 0.330 |
Why?
|
Age Factors | 5 | 2020 | 1527 | 0.320 |
Why?
|
Oxyhemoglobins | 2 | 2020 | 9 | 0.310 |
Why?
|
Signal Transduction | 5 | 2024 | 2893 | 0.310 |
Why?
|
Epitopes, T-Lymphocyte | 5 | 2017 | 178 | 0.310 |
Why?
|
Mutation | 5 | 2018 | 2474 | 0.300 |
Why?
|
Sleep Apnea Syndromes | 2 | 2020 | 27 | 0.300 |
Why?
|
Presenilin-1 | 2 | 2025 | 58 | 0.300 |
Why?
|
Software | 5 | 2019 | 376 | 0.290 |
Why?
|
Immunity | 2 | 2019 | 98 | 0.290 |
Why?
|
Linear Models | 6 | 2019 | 423 | 0.290 |
Why?
|
Heart Ventricles | 2 | 2021 | 251 | 0.290 |
Why?
|
Life Style | 2 | 2020 | 330 | 0.280 |
Why?
|
Atherosclerosis | 2 | 2022 | 148 | 0.280 |
Why?
|
Linkage Disequilibrium | 5 | 2022 | 46 | 0.270 |
Why?
|
Predictive Value of Tests | 5 | 2022 | 1036 | 0.270 |
Why?
|
Factor Xa Inhibitors | 1 | 2007 | 36 | 0.270 |
Why?
|
Connexin 43 | 2 | 2018 | 14 | 0.270 |
Why?
|
Reference Values | 3 | 2025 | 322 | 0.270 |
Why?
|
Cigarette Smoking | 2 | 2017 | 52 | 0.270 |
Why?
|
Sequence Analysis, DNA | 5 | 2014 | 400 | 0.260 |
Why?
|
Amino Acid Sequence | 9 | 2017 | 1583 | 0.260 |
Why?
|
Stroke | 3 | 2023 | 1144 | 0.260 |
Why?
|
Apolipoproteins E | 2 | 2024 | 99 | 0.260 |
Why?
|
Biological Variation, Population | 2 | 2023 | 9 | 0.260 |
Why?
|
Alleles | 8 | 2018 | 423 | 0.260 |
Why?
|
Prognosis | 5 | 2024 | 1592 | 0.260 |
Why?
|
Coronary Disease | 2 | 2018 | 250 | 0.260 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 2052 | 0.260 |
Why?
|
Cross-Sectional Studies | 6 | 2025 | 2507 | 0.260 |
Why?
|
Polymorphism, Genetic | 4 | 2019 | 194 | 0.250 |
Why?
|
Sequence Alignment | 4 | 2007 | 292 | 0.250 |
Why?
|
Myocardium | 2 | 2018 | 263 | 0.250 |
Why?
|
Case-Control Studies | 8 | 2024 | 1066 | 0.250 |
Why?
|
Internet | 3 | 2008 | 465 | 0.250 |
Why?
|
Oxidative Stress | 2 | 2018 | 282 | 0.250 |
Why?
|
Epistasis, Genetic | 2 | 2016 | 43 | 0.250 |
Why?
|
Presenilin-2 | 1 | 2025 | 20 | 0.240 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2006 | 113 | 0.240 |
Why?
|
Aorta, Thoracic | 2 | 2024 | 78 | 0.240 |
Why?
|
Neuroimaging | 2 | 2024 | 131 | 0.240 |
Why?
|
Enzyme Inhibitors | 1 | 2007 | 346 | 0.240 |
Why?
|
United Kingdom | 1 | 2025 | 70 | 0.240 |
Why?
|
Oximetry | 1 | 2025 | 49 | 0.240 |
Why?
|
Peroxidase | 2 | 2016 | 70 | 0.240 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2025 | 60 | 0.240 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2024 | 17 | 0.240 |
Why?
|
Aortic Aneurysm | 2 | 2022 | 84 | 0.240 |
Why?
|
Blood Glucose | 2 | 2025 | 477 | 0.240 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 677 | 0.230 |
Why?
|
Bradycardia | 1 | 2025 | 34 | 0.230 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2025 | 75 | 0.230 |
Why?
|
Prediabetic State | 1 | 2025 | 52 | 0.230 |
Why?
|
Cardiorespiratory Fitness | 1 | 2024 | 9 | 0.230 |
Why?
|
Transcription, Genetic | 3 | 2020 | 848 | 0.230 |
Why?
|
Amyloid beta-Peptides | 3 | 2024 | 195 | 0.230 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2024 | 56 | 0.230 |
Why?
|
Stroke Volume | 3 | 2025 | 323 | 0.230 |
Why?
|
Time Factors | 6 | 2025 | 3623 | 0.220 |
Why?
|
HLA Antigens | 3 | 2017 | 60 | 0.220 |
Why?
|
Sex Factors | 3 | 2024 | 971 | 0.220 |
Why?
|
Receptors, Cell Surface | 2 | 2018 | 436 | 0.220 |
Why?
|
Heterozygote | 2 | 2021 | 166 | 0.220 |
Why?
|
Databases, Factual | 3 | 2021 | 850 | 0.220 |
Why?
|
Pilot Projects | 2 | 2024 | 930 | 0.220 |
Why?
|
Antihypertensive Agents | 2 | 2022 | 173 | 0.220 |
Why?
|
Sex Characteristics | 2 | 2023 | 199 | 0.220 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2017 | 357 | 0.210 |
Why?
|
Viral Load | 1 | 2024 | 229 | 0.210 |
Why?
|
Educational Status | 2 | 2023 | 273 | 0.210 |
Why?
|
Systems Biology | 2 | 2021 | 28 | 0.210 |
Why?
|
Retrospective Studies | 5 | 2022 | 6147 | 0.210 |
Why?
|
Molecular Sequence Data | 7 | 2008 | 1977 | 0.210 |
Why?
|
Mental Disorders | 2 | 2020 | 771 | 0.210 |
Why?
|
Animals | 13 | 2024 | 19775 | 0.210 |
Why?
|
Eicosanoids | 1 | 2022 | 25 | 0.210 |
Why?
|
Prevalence | 4 | 2024 | 1300 | 0.200 |
Why?
|
ROC Curve | 2 | 2017 | 260 | 0.200 |
Why?
|
Death, Sudden, Cardiac | 3 | 2022 | 354 | 0.200 |
Why?
|
Insulin Resistance | 2 | 2023 | 406 | 0.200 |
Why?
|
Connectin | 2 | 2020 | 10 | 0.200 |
Why?
|
Ambulatory Care | 1 | 2025 | 306 | 0.200 |
Why?
|
Interviews as Topic | 1 | 2024 | 495 | 0.200 |
Why?
|
Drug Design | 3 | 2007 | 143 | 0.200 |
Why?
|
Myocytes, Cardiac | 2 | 2025 | 88 | 0.200 |
Why?
|
NAV1.8 Voltage-Gated Sodium Channel | 2 | 2020 | 3 | 0.200 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2022 | 104 | 0.190 |
Why?
|
ADAMTS Proteins | 2 | 2018 | 3 | 0.190 |
Why?
|
Quality Control | 2 | 2018 | 70 | 0.190 |
Why?
|
Esophageal and Gastric Varices | 1 | 2021 | 12 | 0.190 |
Why?
|
Ventricular Function | 1 | 2021 | 21 | 0.190 |
Why?
|
Heart Defects, Congenital | 1 | 2022 | 96 | 0.180 |
Why?
|
Membrane Transport Proteins | 2 | 2024 | 122 | 0.180 |
Why?
|
Ventricular Remodeling | 2 | 2020 | 80 | 0.180 |
Why?
|
End Stage Liver Disease | 1 | 2021 | 31 | 0.180 |
Why?
|
Protein Interaction Maps | 2 | 2017 | 33 | 0.180 |
Why?
|
RNA, Messenger | 2 | 2017 | 1472 | 0.180 |
Why?
|
Mortality | 2 | 2020 | 165 | 0.180 |
Why?
|
NAV1.5 Voltage-Gated Sodium Channel | 2 | 2025 | 5 | 0.180 |
Why?
|
Self Report | 1 | 2023 | 369 | 0.180 |
Why?
|
Atrial Remodeling | 1 | 2020 | 17 | 0.180 |
Why?
|
Smoking | 3 | 2020 | 837 | 0.180 |
Why?
|
Surveys and Questionnaires | 4 | 2024 | 2615 | 0.180 |
Why?
|
Antigens, CD1d | 1 | 2020 | 27 | 0.180 |
Why?
|
Qualitative Research | 1 | 2024 | 633 | 0.170 |
Why?
|
Aptamers, Nucleotide | 1 | 2020 | 18 | 0.170 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2020 | 29 | 0.170 |
Why?
|
Molecular Sequence Annotation | 1 | 2020 | 59 | 0.170 |
Why?
|
Diabetes Mellitus | 1 | 2025 | 538 | 0.170 |
Why?
|
Cell Adhesion Molecules | 2 | 2017 | 88 | 0.170 |
Why?
|
Risk | 1 | 2020 | 377 | 0.170 |
Why?
|
Fitness Trackers | 1 | 2019 | 19 | 0.160 |
Why?
|
rab GTP-Binding Proteins | 1 | 2020 | 80 | 0.160 |
Why?
|
United States | 7 | 2022 | 7623 | 0.160 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 3222 | 0.160 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 151 | 0.160 |
Why?
|
Quantitative Structure-Activity Relationship | 3 | 2007 | 11 | 0.160 |
Why?
|
Nutrition Policy | 1 | 2019 | 49 | 0.160 |
Why?
|
Energy Intake | 2 | 2017 | 213 | 0.160 |
Why?
|
Membrane Proteins | 3 | 2022 | 848 | 0.160 |
Why?
|
Connective Tissue Growth Factor | 1 | 2019 | 6 | 0.160 |
Why?
|
Databases, Genetic | 1 | 2019 | 85 | 0.160 |
Why?
|
Neurodevelopmental Disorders | 1 | 2019 | 35 | 0.160 |
Why?
|
Aftercare | 1 | 2019 | 67 | 0.160 |
Why?
|
Primary Health Care | 1 | 2025 | 660 | 0.160 |
Why?
|
Down-Regulation | 1 | 2020 | 306 | 0.160 |
Why?
|
Collagen Type I | 1 | 2019 | 38 | 0.160 |
Why?
|
Air Pollutants, Radioactive | 1 | 2018 | 1 | 0.160 |
Why?
|
Amino Acids | 3 | 2016 | 139 | 0.160 |
Why?
|
Loss of Function Mutation | 1 | 2018 | 20 | 0.160 |
Why?
|
Genetic Markers | 4 | 2023 | 122 | 0.160 |
Why?
|
Atrial Function | 1 | 2018 | 4 | 0.150 |
Why?
|
Atrioventricular Node | 1 | 2018 | 9 | 0.150 |
Why?
|
Electrophysiological Phenomena | 1 | 2018 | 23 | 0.150 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 128 | 0.150 |
Why?
|
Thyroid Gland | 1 | 2019 | 78 | 0.150 |
Why?
|
Genotyping Techniques | 1 | 2018 | 14 | 0.150 |
Why?
|
Renin | 2 | 2015 | 9 | 0.150 |
Why?
|
Protein Kinase C-alpha | 1 | 2018 | 16 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 263 | 0.150 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 74 | 0.150 |
Why?
|
Alcohol Drinking | 1 | 2020 | 305 | 0.150 |
Why?
|
Albuminuria | 1 | 2018 | 24 | 0.150 |
Why?
|
Cardiomyopathies | 1 | 2020 | 120 | 0.150 |
Why?
|
Ion Channel Gating | 1 | 2018 | 44 | 0.150 |
Why?
|
Environmental Exposure | 2 | 2018 | 212 | 0.150 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2017 | 2 | 0.150 |
Why?
|
Filamins | 1 | 2017 | 7 | 0.150 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 639 | 0.150 |
Why?
|
Morbidity | 1 | 2018 | 110 | 0.150 |
Why?
|
Inflammation Mediators | 2 | 2017 | 170 | 0.150 |
Why?
|
Phospholipase C gamma | 1 | 2017 | 9 | 0.140 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2018 | 96 | 0.140 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 88 | 0.140 |
Why?
|
Human Embryonic Stem Cells | 1 | 2017 | 33 | 0.140 |
Why?
|
Cell-Free Nucleic Acids | 1 | 2017 | 11 | 0.140 |
Why?
|
Demography | 1 | 2018 | 178 | 0.140 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2017 | 4 | 0.140 |
Why?
|
Hand Strength | 1 | 2017 | 29 | 0.140 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2018 | 122 | 0.140 |
Why?
|
Action Potentials | 1 | 2017 | 103 | 0.140 |
Why?
|
Platelet Aggregation | 1 | 2017 | 27 | 0.140 |
Why?
|
Multivariate Analysis | 2 | 2016 | 928 | 0.140 |
Why?
|
Protein Binding | 4 | 2011 | 1572 | 0.140 |
Why?
|
Phospholipase A2 Inhibitors | 1 | 2016 | 1 | 0.140 |
Why?
|
Angiopoietin-2 | 1 | 2016 | 3 | 0.140 |
Why?
|
Oximes | 1 | 2016 | 11 | 0.140 |
Why?
|
Homeobox Protein Nkx-2.5 | 1 | 2016 | 1 | 0.140 |
Why?
|
Benzaldehydes | 1 | 2016 | 4 | 0.140 |
Why?
|
Europe | 4 | 2022 | 184 | 0.140 |
Why?
|
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2016 | 2 | 0.140 |
Why?
|
GATA6 Transcription Factor | 1 | 2016 | 3 | 0.140 |
Why?
|
Aortic Valve | 1 | 2018 | 172 | 0.140 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2016 | 7 | 0.140 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2016 | 8 | 0.140 |
Why?
|
Receptors, Immunologic | 1 | 2017 | 177 | 0.130 |
Why?
|
Potassium Channels | 1 | 2016 | 53 | 0.130 |
Why?
|
Epitopes | 2 | 2008 | 295 | 0.130 |
Why?
|
Dinoprost | 1 | 2016 | 17 | 0.130 |
Why?
|
Antigens, Neoplasm | 1 | 2017 | 136 | 0.130 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 118 | 0.130 |
Why?
|
Air Pollution | 1 | 2016 | 34 | 0.130 |
Why?
|
Blood Platelets | 1 | 2017 | 101 | 0.130 |
Why?
|
Metabolic Syndrome | 2 | 2014 | 149 | 0.130 |
Why?
|
Depressive Disorder, Major | 1 | 2019 | 261 | 0.130 |
Why?
|
Oxygen Consumption | 1 | 2016 | 204 | 0.130 |
Why?
|
Oligopeptides | 2 | 2006 | 129 | 0.130 |
Why?
|
Neoplasms | 2 | 2017 | 1262 | 0.130 |
Why?
|
Muscle Strength | 1 | 2015 | 37 | 0.130 |
Why?
|
Flavonols | 1 | 2015 | 1 | 0.120 |
Why?
|
Nuclear Proteins | 2 | 2024 | 760 | 0.120 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 481 | 0.120 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 584 | 0.120 |
Why?
|
Anthocyanins | 1 | 2015 | 15 | 0.120 |
Why?
|
Receptor, TIE-2 | 1 | 2014 | 7 | 0.120 |
Why?
|
Hepatocyte Growth Factor | 1 | 2014 | 13 | 0.120 |
Why?
|
Energy Metabolism | 1 | 2017 | 351 | 0.120 |
Why?
|
Kininogens | 1 | 2014 | 1 | 0.120 |
Why?
|
Prekallikrein | 1 | 2014 | 1 | 0.120 |
Why?
|
Base Sequence | 3 | 2020 | 1313 | 0.120 |
Why?
|
Renin-Angiotensin System | 1 | 2014 | 22 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 11 | 1 | 2014 | 2 | 0.120 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2015 | 52 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2014 | 8 | 0.120 |
Why?
|
Computer Simulation | 3 | 2007 | 461 | 0.120 |
Why?
|
Genetic Pleiotropy | 1 | 2014 | 3 | 0.120 |
Why?
|
T-Box Domain Proteins | 1 | 2014 | 40 | 0.120 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 118 | 0.110 |
Why?
|
Microglia | 1 | 2017 | 229 | 0.110 |
Why?
|
Zebrafish | 4 | 2018 | 323 | 0.110 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2014 | 17 | 0.110 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 669 | 0.110 |
Why?
|
Vesicular Transport Proteins | 1 | 2014 | 105 | 0.110 |
Why?
|
Chromatin | 3 | 2025 | 603 | 0.110 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 161 | 0.110 |
Why?
|
Interleukins | 1 | 2013 | 78 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2013 | 157 | 0.110 |
Why?
|
Kidney Diseases | 1 | 2014 | 160 | 0.110 |
Why?
|
Catheter Ablation | 1 | 2014 | 141 | 0.100 |
Why?
|
Boston | 3 | 2024 | 336 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 207 | 0.100 |
Why?
|
Epitope Mapping | 2 | 2011 | 47 | 0.100 |
Why?
|
Systole | 1 | 2012 | 110 | 0.100 |
Why?
|
Support Vector Machine | 1 | 2012 | 23 | 0.100 |
Why?
|
Enzymes | 1 | 2012 | 33 | 0.100 |
Why?
|
T-Lymphocytes | 1 | 2017 | 970 | 0.100 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 678 | 0.100 |
Why?
|
Organ Size | 2 | 2024 | 165 | 0.100 |
Why?
|
Repressor Proteins | 1 | 2014 | 337 | 0.100 |
Why?
|
Electronics | 2 | 2023 | 37 | 0.100 |
Why?
|
Genetic Research | 1 | 2011 | 8 | 0.100 |
Why?
|
Depression | 1 | 2019 | 868 | 0.100 |
Why?
|
Brain Ischemia | 1 | 2015 | 402 | 0.100 |
Why?
|
Allergy and Immunology | 1 | 2011 | 7 | 0.090 |
Why?
|
Immunity, Innate | 1 | 2017 | 766 | 0.090 |
Why?
|
Models, Molecular | 4 | 2013 | 1139 | 0.090 |
Why?
|
Research Design | 1 | 2014 | 569 | 0.090 |
Why?
|
Cluster Analysis | 2 | 2023 | 252 | 0.090 |
Why?
|
Evolution, Molecular | 1 | 2012 | 296 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2023 | 1100 | 0.080 |
Why?
|
Models, Theoretical | 2 | 2008 | 258 | 0.080 |
Why?
|
Protein Structure, Tertiary | 2 | 2013 | 666 | 0.080 |
Why?
|
Genetic Testing | 2 | 2022 | 132 | 0.080 |
Why?
|
Cardiology | 1 | 2011 | 163 | 0.080 |
Why?
|
Random Allocation | 2 | 2022 | 197 | 0.080 |
Why?
|
Disease Progression | 2 | 2024 | 1054 | 0.080 |
Why?
|
Molecular Structure | 2 | 2007 | 379 | 0.080 |
Why?
|
Markov Chains | 1 | 2008 | 37 | 0.080 |
Why?
|
False Positive Reactions | 1 | 2008 | 74 | 0.080 |
Why?
|
Protein Conformation | 3 | 2006 | 774 | 0.080 |
Why?
|
Plasma | 2 | 2021 | 34 | 0.070 |
Why?
|
Antigens | 1 | 2008 | 146 | 0.070 |
Why?
|
Data Compression | 1 | 2007 | 9 | 0.070 |
Why?
|
Computer Communication Networks | 1 | 2007 | 13 | 0.070 |
Why?
|
Database Management Systems | 1 | 2007 | 20 | 0.070 |
Why?
|
Drug Resistance, Bacterial | 1 | 2008 | 82 | 0.070 |
Why?
|
Age of Onset | 2 | 2018 | 171 | 0.070 |
Why?
|
Mutation, Missense | 2 | 2018 | 180 | 0.070 |
Why?
|
Developing Countries | 1 | 2007 | 85 | 0.070 |
Why?
|
Staphylococcus aureus | 1 | 2008 | 161 | 0.070 |
Why?
|
Information Storage and Retrieval | 1 | 2007 | 80 | 0.070 |
Why?
|
Particulate Matter | 2 | 2018 | 59 | 0.070 |
Why?
|
Structural Homology, Protein | 1 | 2006 | 21 | 0.070 |
Why?
|
Young Adult | 4 | 2019 | 4401 | 0.070 |
Why?
|
Metals | 1 | 2006 | 62 | 0.070 |
Why?
|
Information Dissemination | 1 | 2007 | 119 | 0.070 |
Why?
|
Mice | 4 | 2024 | 10340 | 0.070 |
Why?
|
Pedigree | 2 | 2016 | 191 | 0.070 |
Why?
|
Binding Sites | 1 | 2008 | 893 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2007 | 216 | 0.060 |
Why?
|
Probability | 1 | 2006 | 173 | 0.060 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2006 | 179 | 0.060 |
Why?
|
Models, Chemical | 1 | 2006 | 135 | 0.060 |
Why?
|
Cardiac Conduction System Disease | 1 | 2025 | 2 | 0.060 |
Why?
|
Sick Sinus Syndrome | 1 | 2025 | 4 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2016 | 1565 | 0.060 |
Why?
|
Aldosterone | 2 | 2015 | 15 | 0.060 |
Why?
|
Plant Proteins | 1 | 2005 | 83 | 0.060 |
Why?
|
Dilatation, Pathologic | 1 | 2024 | 28 | 0.060 |
Why?
|
Speech Acoustics | 1 | 2024 | 8 | 0.060 |
Why?
|
Voice | 1 | 2024 | 7 | 0.060 |
Why?
|
Drug Resistance | 1 | 2005 | 92 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2006 | 354 | 0.060 |
Why?
|
Japan | 2 | 2014 | 57 | 0.060 |
Why?
|
Pacemaker, Artificial | 1 | 2025 | 42 | 0.060 |
Why?
|
Recurrence | 2 | 2016 | 600 | 0.060 |
Why?
|
Non-ST Elevated Myocardial Infarction | 1 | 2024 | 33 | 0.060 |
Why?
|
Data Accuracy | 1 | 2024 | 27 | 0.060 |
Why?
|
Kinetics | 1 | 2006 | 737 | 0.060 |
Why?
|
Censuses | 1 | 2023 | 15 | 0.060 |
Why?
|
Escherichia coli | 1 | 2008 | 688 | 0.050 |
Why?
|
Nucleic Acids | 1 | 2004 | 50 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2024 | 194 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2024 | 118 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2018 | 2103 | 0.050 |
Why?
|
Diglycerides | 1 | 2023 | 22 | 0.050 |
Why?
|
ST Elevation Myocardial Infarction | 1 | 2024 | 77 | 0.050 |
Why?
|
Gray Matter | 1 | 2023 | 29 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 164 | 0.050 |
Why?
|
Body Weights and Measures | 1 | 2022 | 34 | 0.050 |
Why?
|
Exercise Test | 1 | 2024 | 237 | 0.050 |
Why?
|
Early Diagnosis | 1 | 2023 | 90 | 0.050 |
Why?
|
Sample Size | 1 | 2022 | 59 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2016 | 685 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2008 | 734 | 0.050 |
Why?
|
Georgia | 1 | 2022 | 88 | 0.050 |
Why?
|
Ventricular Function, Right | 1 | 2022 | 27 | 0.050 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 79 | 0.050 |
Why?
|
Social Networking | 1 | 2022 | 23 | 0.050 |
Why?
|
Phosphorylation | 1 | 2024 | 861 | 0.050 |
Why?
|
Waist Circumference | 1 | 2022 | 53 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2023 | 498 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2024 | 531 | 0.050 |
Why?
|
Consensus | 1 | 2023 | 199 | 0.050 |
Why?
|
Blood Component Transfusion | 1 | 2021 | 8 | 0.050 |
Why?
|
Epigenomics | 1 | 2021 | 55 | 0.050 |
Why?
|
Effect Modifier, Epidemiologic | 1 | 2020 | 8 | 0.050 |
Why?
|
Chromosome Structures | 1 | 2020 | 7 | 0.040 |
Why?
|
Data Collection | 1 | 2022 | 383 | 0.040 |
Why?
|
Endophenotypes | 1 | 2020 | 8 | 0.040 |
Why?
|
Cardiac Myosins | 1 | 2020 | 22 | 0.040 |
Why?
|
Norway | 1 | 2020 | 19 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 2020 | 42 | 0.040 |
Why?
|
Atrial Function, Left | 1 | 2020 | 31 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 86 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 1387 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2020 | 153 | 0.040 |
Why?
|
rho-Associated Kinases | 1 | 2020 | 11 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2020 | 101 | 0.040 |
Why?
|
Matrix Metalloproteinase 20 | 1 | 2019 | 1 | 0.040 |
Why?
|
Ankyrins | 1 | 2019 | 3 | 0.040 |
Why?
|
Tissue Donors | 1 | 2020 | 134 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2020 | 52 | 0.040 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2020 | 83 | 0.040 |
Why?
|
Genetics, Population | 1 | 2019 | 41 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2020 | 233 | 0.040 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 74 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2022 | 742 | 0.040 |
Why?
|
Integrins | 1 | 2019 | 106 | 0.040 |
Why?
|
Hyperthyroidism | 1 | 2019 | 17 | 0.040 |
Why?
|
Thyroid Function Tests | 1 | 2019 | 13 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2020 | 149 | 0.040 |
Why?
|
Iodide Peroxidase | 1 | 2019 | 23 | 0.040 |
Why?
|
Triiodothyronine | 1 | 2019 | 26 | 0.040 |
Why?
|
Thyrotropin | 1 | 2019 | 33 | 0.040 |
Why?
|
Soot | 1 | 2018 | 9 | 0.040 |
Why?
|
Thyroxine | 1 | 2019 | 53 | 0.040 |
Why?
|
Hypothyroidism | 1 | 2019 | 39 | 0.040 |
Why?
|
Aerosols | 1 | 2018 | 44 | 0.040 |
Why?
|
Insulin-Secreting Cells | 1 | 2020 | 177 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2018 | 48 | 0.040 |
Why?
|
Biophysical Phenomena | 1 | 2018 | 22 | 0.040 |
Why?
|
Open Reading Frames | 1 | 2018 | 81 | 0.040 |
Why?
|
Models, Statistical | 1 | 2020 | 309 | 0.040 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2018 | 6 | 0.040 |
Why?
|
Antiporters | 1 | 2018 | 7 | 0.040 |
Why?
|
Homozygote | 1 | 2018 | 116 | 0.040 |
Why?
|
Decision Trees | 1 | 2018 | 52 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 278 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2019 | 387 | 0.040 |
Why?
|
A549 Cells | 1 | 2017 | 36 | 0.040 |
Why?
|
Syndrome | 1 | 2017 | 173 | 0.040 |
Why?
|
Data Mining | 1 | 2018 | 47 | 0.040 |
Why?
|
Introns | 1 | 2018 | 106 | 0.040 |
Why?
|
Community-Based Participatory Research | 1 | 2017 | 46 | 0.040 |
Why?
|
Population Groups | 1 | 2017 | 12 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2018 | 244 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2020 | 417 | 0.040 |
Why?
|
Lipid Metabolism | 1 | 2019 | 203 | 0.040 |
Why?
|
Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 1 | 0.040 |
Why?
|
Age Distribution | 1 | 2018 | 262 | 0.040 |
Why?
|
NADPH Oxidase 4 | 1 | 2017 | 5 | 0.030 |
Why?
|
Procollagen N-Endopeptidase | 1 | 2017 | 3 | 0.030 |
Why?
|
Somatomedins | 1 | 2017 | 4 | 0.030 |
Why?
|
Adenosine Diphosphate | 1 | 2017 | 41 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 165 | 0.030 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 6 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2018 | 177 | 0.030 |
Why?
|
Health Status | 1 | 2020 | 451 | 0.030 |
Why?
|
Databases as Topic | 1 | 2017 | 53 | 0.030 |
Why?
|
Epinephrine | 1 | 2017 | 42 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2017 | 37 | 0.030 |
Why?
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2016 | 7 | 0.030 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2016 | 3 | 0.030 |
Why?
|
Proteoglycans | 1 | 2017 | 33 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2017 | 28 | 0.030 |
Why?
|
Glycosaminoglycans | 1 | 2017 | 18 | 0.030 |
Why?
|
Metabolic Diseases | 1 | 2017 | 52 | 0.030 |
Why?
|
NADPH Oxidases | 1 | 2017 | 64 | 0.030 |
Why?
|
Interferon Regulatory Factors | 1 | 2017 | 39 | 0.030 |
Why?
|
Genetic Linkage | 1 | 2016 | 101 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 281 | 0.030 |
Why?
|
Nucleotide Motifs | 1 | 2016 | 50 | 0.030 |
Why?
|
Comorbidity | 1 | 2020 | 1099 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2016 | 59 | 0.030 |
Why?
|
Nitrogen Oxides | 1 | 2016 | 8 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2018 | 450 | 0.030 |
Why?
|
Sulfates | 1 | 2016 | 14 | 0.030 |
Why?
|
Ozone | 1 | 2016 | 14 | 0.030 |
Why?
|
Schizophrenia | 1 | 2018 | 256 | 0.030 |
Why?
|
Leukocytes | 1 | 2016 | 99 | 0.030 |
Why?
|
RNA, Long Noncoding | 1 | 2018 | 151 | 0.030 |
Why?
|
Respiration | 1 | 2016 | 88 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 196 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2016 | 121 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2021 | 1471 | 0.030 |
Why?
|
Child | 2 | 2018 | 4334 | 0.030 |
Why?
|
Hedgehog Proteins | 1 | 2017 | 113 | 0.030 |
Why?
|
Creatinine | 1 | 2016 | 123 | 0.030 |
Why?
|
Carbon | 1 | 2016 | 47 | 0.030 |
Why?
|
Bipolar Disorder | 1 | 2018 | 254 | 0.030 |
Why?
|
Fibrinogen | 1 | 2015 | 31 | 0.030 |
Why?
|
Family | 1 | 2017 | 224 | 0.030 |
Why?
|
Proteolysis | 1 | 2017 | 137 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 155 | 0.030 |
Why?
|
Gene Ontology | 1 | 2015 | 38 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2017 | 213 | 0.030 |
Why?
|
Oxidoreductases | 1 | 2015 | 65 | 0.030 |
Why?
|
Glycoproteins | 1 | 2017 | 194 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 2007 | 376 | 0.030 |
Why?
|
Knee | 1 | 2015 | 36 | 0.030 |
Why?
|
Pyrus | 1 | 2015 | 1 | 0.030 |
Why?
|
Flavanones | 1 | 2015 | 2 | 0.030 |
Why?
|
Protein Transport | 1 | 2017 | 398 | 0.030 |
Why?
|
Potassium, Dietary | 1 | 2015 | 3 | 0.030 |
Why?
|
Malus | 1 | 2015 | 6 | 0.030 |
Why?
|
Air Pollutants | 1 | 2016 | 84 | 0.030 |
Why?
|
Odds Ratio | 1 | 2017 | 774 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 1481 | 0.030 |
Why?
|
Observational Studies as Topic | 1 | 2015 | 61 | 0.030 |
Why?
|
Mississippi | 1 | 2015 | 33 | 0.030 |
Why?
|
Ascorbic Acid | 1 | 2015 | 51 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2016 | 288 | 0.030 |
Why?
|
Oxygen | 1 | 2016 | 309 | 0.030 |
Why?
|
Adolescent | 2 | 2018 | 5961 | 0.030 |
Why?
|
Hydrogen Bonding | 2 | 2006 | 125 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2014 | 10 | 0.030 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2014 | 1 | 0.030 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2014 | 2 | 0.030 |
Why?
|
Thermodynamics | 2 | 2006 | 197 | 0.030 |
Why?
|
Drosophila | 1 | 2017 | 420 | 0.030 |
Why?
|
User-Computer Interface | 2 | 2006 | 131 | 0.030 |
Why?
|
Fruit | 1 | 2015 | 124 | 0.030 |
Why?
|
Flavones | 1 | 2015 | 53 | 0.030 |
Why?
|
Dyslipidemias | 1 | 2014 | 34 | 0.030 |
Why?
|
Liver | 1 | 2018 | 788 | 0.030 |
Why?
|
Myelin and Lymphocyte-Associated Proteolipid Proteins | 1 | 2013 | 12 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 193 | 0.030 |
Why?
|
Interleukin-1 Receptor-Like 1 Protein | 1 | 2013 | 7 | 0.030 |
Why?
|
Interleukin-33 | 1 | 2013 | 18 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2018 | 2002 | 0.030 |
Why?
|
Transcription Factor AP-1 | 1 | 2013 | 41 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2014 | 150 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 806 | 0.030 |
Why?
|
Cell Line | 1 | 2017 | 2019 | 0.030 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2013 | 207 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 252 | 0.030 |
Why?
|
Diastole | 1 | 2012 | 89 | 0.030 |
Why?
|
Motor Activity | 1 | 2015 | 343 | 0.020 |
Why?
|
Academies and Institutes | 1 | 2011 | 22 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2018 | 1142 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2018 | 2081 | 0.020 |
Why?
|
NF-kappa B | 1 | 2013 | 463 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2013 | 586 | 0.020 |
Why?
|
Logistic Models | 1 | 2014 | 1262 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 664 | 0.020 |
Why?
|
Diet | 1 | 2015 | 638 | 0.020 |
Why?
|
Folic Acid Antagonists | 1 | 2007 | 4 | 0.020 |
Why?
|
Central Nervous System Agents | 1 | 2007 | 6 | 0.020 |
Why?
|
Chemistry, Physical | 1 | 2007 | 47 | 0.020 |
Why?
|
Genome, Bacterial | 1 | 2008 | 62 | 0.020 |
Why?
|
Pharmacology | 1 | 2007 | 5 | 0.020 |
Why?
|
Pharmacokinetics | 1 | 2007 | 7 | 0.020 |
Why?
|
Dopamine Antagonists | 1 | 2007 | 15 | 0.020 |
Why?
|
Biometry | 1 | 2007 | 11 | 0.020 |
Why?
|
Chemical Phenomena | 1 | 2007 | 93 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2012 | 1317 | 0.020 |
Why?
|
Pattern Recognition, Automated | 1 | 2007 | 61 | 0.020 |
Why?
|
Infant | 1 | 2012 | 1532 | 0.020 |
Why?
|
Models, Biological | 1 | 2012 | 1144 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 1850 | 0.020 |
Why?
|
HIV Protease Inhibitors | 1 | 2007 | 106 | 0.020 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2007 | 254 | 0.020 |
Why?
|
Genes, MHC Class II | 1 | 2006 | 37 | 0.020 |
Why?
|
Genes, MHC Class I | 1 | 2006 | 28 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 2007 | 122 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2016 | 5267 | 0.020 |
Why?
|
Plant Physiological Phenomena | 1 | 2005 | 4 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2007 | 169 | 0.020 |
Why?
|
Computing Methodologies | 1 | 2005 | 2 | 0.020 |
Why?
|
Static Electricity | 1 | 2006 | 165 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2007 | 279 | 0.010 |
Why?
|
Ligands | 1 | 2006 | 420 | 0.010 |
Why?
|
Vibration | 1 | 2004 | 26 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2007 | 579 | 0.010 |
Why?
|
HIV-1 | 1 | 2006 | 710 | 0.010 |
Why?
|